Abstract
BACKGROUND: The FOXP2 gene, crucial for speech and motor functions, exhibits sex-specific expression differences. In premature infants, elevated FOXP2 expression, particularly in females, correlates with improved oral feeding readiness, indicating the potential for enhancing neonatal care. OBJECTIVE: This study investigates FOXP2 gene expression in premature newborns across five feeding stages using salivary RNA, focusing on sex differences and their impact on oral feeding readiness to refine neonatal clinical protocols. METHODS: FOXP2 expression was analyzed using RT-qPCR and the ΔΔCt method across five feeding stages in 45 premature newborns using saliva-derived RNA (n = 225). RESULTS: FOXP2 expression increased significantly through feeding stages, especially in full oral feeding. Female infants showed consistently higher expression levels than males, with 58% higher expression by stage 5. Significant sex differences were apparent from stage 2. CONCLUSIONS: FOXP2 expression impacts neuromuscular coordination and feeding readiness in preterm infants. The sex differences suggest that FOXP2 could serve as a non-invasive biomarker for predicting oral feeding readiness, potentially improving clinical outcomes. PERSPECTIVES: FOXP2 gene expression correlates with better oral feeding readiness in premature infants and may serve as a non-invasive biomarker to improve neonatal care. The study could enhance neonatal care, leading to improved outcomes and reduced hospital stays for preterm infants.